Worried about your symptoms?
Start the Pathologic Myopia test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Blurred vision
Difficulty seeing distant objects
Poor vision
Difficult to see things when dark
Headache due to eye strain
Sensitive to bright light
Seeing flashes of light
Squint to see things
Colors look different
Blind spots in vision
Hard to see in low light
See small objects floating in vision
Not seeing your symptoms? No worries!
Pathologic myopia is a type of farsightedness that causes the eyeball to elongate, resulting in high myopic refractive power. It is accompanied by degenerative changes in the eye and may lead to vision loss.
Your doctor may ask these questions to check for this disease:
Treatment options include photodynamic therapy, which involves injecting drugs into the retina at regular intervals and using laser radiation. For patients with low vision, visual aids can help them perform daily routines with ease.
Reviewed By:
Kenji Taylor, MD, MSc (Family Medicine, Primary Care)
Dr. Taylor is a Japanese-African American physician who grew up and was educated in the United States but spent a considerable amount of time in Japan as a college student, working professional and now father of three. After graduating from Brown, he worked in finance first before attending medical school at Penn. He then completed a fellowship with the Centers for Disease Control before going on to specialize in Family and Community Medicine at the University of California, San Francisco (UCSF) where he was also a chief resident. After a faculty position at Stanford, he moved with his family to Japan where he continues to see families on a military base outside of Tokyo, teach Japanese residents and serve remotely as a medical director for Roots Community Health Center. He also enjoys editing and writing podcast summaries for Hippo Education.
Masashi Mimura, MD (Ophthalmology)
Dr. Mimura Graduated from the Osaka Medical College and obtained his ophthalmologist certification in 2007. He opened an outpatient clinic for oculoplastic and reconstructive surgery at Osaka Kaijo Hospital. Subsequently, he was appointed as the assistant professor at the Department of Ophthalmology, Osaka Medical College, in 2014. He then served an international fellowship at the Department of Ophthalmology/Oculoplastic and Reconstructive Surgery, California State University, San Diego. Since then, he has been appointed as Lecturer in the Departments of Ophthalmology at Osaka Medical College and Toho University Medical Center Sakura Hospital. Dr. Mimura is currently the Director of Oculofacial Clinic Osaka, where he specializes in Oculofacial Plastic and Reconstructive Surgery.
Content updated on Feb 3, 2025
Following the Medical Content Editorial Policy
Was this page helpful?
We would love to help them too.
With a free 3-min Pathologic Myopia quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1Ueta T, Makino S, Yamamoto Y, Fukushima H, Yashiro S, Nagahara M. Pathologic myopia: an overview of the current understanding and interventions. Glob Health Med. 2020 Jun 30;2(3):151-155. doi: 10.35772/ghm.2020.01007. PMID: 33330799; PMCID: PMC7731360.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7731360/Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatorn K, Fang Y, Cheung CMG, Lai TYY, Ikuno Y, Cohen SY, Gaudric A, Jonas JB. IMI Pathologic Myopia. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5. doi: 10.1167/iovs.62.5.5. Erratum in: Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):17. doi: 10.1167/iovs.62.7.17. PMID: 33909033; PMCID: PMC8083114.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8083114/Arnal, L., Salvi, A., Thomas, M. et al. Social determinants of health in high and pathologic myopia screening. Eye (2024).
https://www.nature.com/articles/s41433-024-03561-9